Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Lands Leading China Life Sciences Lawyer

May 5, 2011

BEIJING, May 5, 2011 — Covington & Burling LLP is pleased to announce that Shaoyu Chen has joined the firm as managing director of the firm’s China food and drug practice.

Mr. Chen’s experience in food and drug law includes serving as assistant chief counsel in the U.S. Food and Drug Administration’s Office of Chief Counsel, as senior counsel at California-based Amgen Inc., and as chief compliance counsel for GE Healthcare (China).

Mr. Chen advises Asian, European and North American pharmaceutical, biotechnology, medical device, food, dietary supplement, and cosmetic companies about policies from the FDA and State Food Drug Administration in China. He also advises clients on legal issues pertaining to preclinical research, clinical trials, marketing approval, advertising and promotion, Good Manufacturing Practice, pharmacovigilance, import and export, and compliance with FCPA and the China Anti-Unfair Competition Law.

“Shaoyu understands regulatory compliance matters from the SFDA perspective as well as the FDA perspective--which is critical for our globally focused food and drug clients,” said Ellen Flannery, co-chair of Covington’s food and drug practice.

Mr. Chen added: “I am delighted to be joining Covington, which has one of the preeminent food and drug practices in the world. I look forward to working with my distinguished colleagues advising clients on a range of life sciences matters, particularly as they relate to China.”

A native of China, Mr. Chen received his undergraduate degree from Peking University in 1985 and his law degree from the University of Nebraska College of Law in 2000.

Mr. Chen enhances the firm’s already strong regulatory capability in the China food and drug practice. The firm’s team focused on those issues includes Scott Cunningham, who represents pharmaceutical, biotechnology, and medical device companies as well as trade associations in matters before the FDA, Congress, and state and federal courts; Jason Ma, who focuses on complex food and drug regulatory compliance matters; and Jay Friedman, who oversees the firm's global organic products practice and teaches food and drug law at Tsinghua University Law School.

Share this article: